share_log

BTIG Maintains Buy on DermTech, Lowers Price Target to $5

Benzinga ·  Aug 7, 2023 11:03

BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment